Digital Pharmacy Licence UAE: DHA, DoH and MOHAP

Three regulators divide the UAE for this activity: DHA for Dubai, DoH for Abu Dhabi, and MOHAP for the remaining emirates. A pharmacy trading from Dubai answers to DHA regardless of where its holding company or free-zone licence sits, and the same applies to DoH in Abu Dhabi. A founder cannot pick the friendliest regulator by choosing a free zone, because the facility's physical location fixes the authority.

A second line runs alongside this: the role, not just the premises. MOHAP's own licensing service for pharmacists treats the employer facility, rather than the individual, as the applicant, which means a pharmacy cannot open with a vacant pharmacist post and fill it later. The pharmacist-in-charge and any additional pharmacists or pharmacy technicians need their own licence before the premises can trade, and that licence is tied to the specific facility that applied for it.

Adding a website, app or delivery fleet does not create a lighter licensing path. The dispensing step (checking a prescription, selecting the medicine, counselling the patient) still has to happen under a licensed pharmacist attached to a licensed facility, whether the order arrived at the counter or through a screen. A platform that holds no stock and only routes an order to a pharmacy that fulfils and dispenses it is a different question. Its contracts with those pharmacies, and who is responsible for the dispensing decision, are what a regulator or a bank will test, not the branding on the app. In Dubai, DHA's Manual for Licensing Health Facility lists pharmacy delivery and pharmacy drive-thru as add-ons to a facility licence, requested through an amendment application, so a delivery channel is approved against the pharmacy licence rather than set up on its own.

Where the platform or pharmacy stores health or order data electronically, the federal Personal Data Protection Law (Federal Decree Law No. 45 of 2021) applies on top of health-authority rules: processing needs the data owner's consent, subject to defined exceptions, and the data must be held securely and confidentially. The ICT in Health Fields Law (Federal Law No. 2 of 2019) separately regulates technology use in healthcare, including in free zones, so a digital-pharmacy build should be reviewed against both laws, not treated as a generic e-commerce project.

Beyond the pharmacist-in-charge, the health authority is checking who stands behind the facility: the licensed owner or operator, the premises itself, and the chain of responsibility if a dispensing error occurs. Where ownership includes more than one shareholder, a holding structure, or an overseas investor, the regulated and complex ownership route needs mapping early, because the facility licence application asks for the real controlling parties, not a simplified version held back for later.

A founder bringing in outside capital or a corporate group structure should also prepare a source-of-wealth and source-of-funds file alongside the facility application. Health-authority licensing and bank account opening both test the same underlying question: who actually owns and controls the money behind the pharmacy. Inconsistent answers between the two slow both down.

The recurring error is treating a trade licence or an e-commerce registration as if it were pharmacy authorisation. A commercial registration lets a company exist; it says nothing about whether that company may hold, store or dispense medicine. A second common error is building a delivery or marketplace model around generic couriers for temperature-sensitive stock, without first confirming the cold-chain and storage conditions the facility licence itself depends on. A third is assuming a pharmacist appointment can follow the premises approval rather than precede it, which stalls opening once the facility is otherwise ready. In Dubai, the first approval DHA issues is an inactive facility licence valid for one year, and during that period the facility may not provide healthcare services, receive patients or promote or advertise any health services.

Banks assessing a pharmacy or digital-pharmacy account want the facility licence, the pharmacist-in-charge appointment, the ownership structure, and a credible description of how money moves: cash and card at the counter, online payment for delivery, or invoiced supply to another facility. A platform routing payment through several contracted pharmacies needs a clear explanation of who is paid and under whose name the sale is recorded; that detail is what corporate bank account readiness work is built around, and mismatches are a common reason onboarding stalls.

The facility licence, the pharmacist licences and the commercial registration need to stay aligned as the business operates: a change of pharmacist-in-charge, a change of premises, or the addition of a delivery service each has its own notification or approval step with the health authority, separate from any commercial-licence renewal. Visas for pharmacists and pharmacy technicians depend on the licensed facility sponsoring them, so a gap in the facility licence can stall staff visas as well as trading. In Dubai the facility licence can be activated for one, two or three years, renewal may start three months before expiry, and a licence left unrenewed for more than six months is treated as cancelled. Cost is built in layers across formation, facility and professional approvals, and ongoing renewals, and the Velarozone service fee for that work is itemised in the engagement letter rather than quoted as one figure; see how Velarozone works for that process.